Pharma Times

AUGUST 20, 2020

The Phase III study is evaluating the safety, tolerability and immunogenicity of GSK’s MenABCWY vaccine candidate compared to Bexsero and Menveo

Vaccines 177

Vaccines 177

NY Times

AUGUST 19, 2020

Government health leaders including Dr. Francis S. Collins and Dr. Anthony S. Fauci urged caution last week, citing weak data from the country’s largest plasma study.

144

144

pharmaphorum

AUGUST 18, 2020

Pharma companies have improved how they engage with healthcare providers as a result of COVID-19, according to a new survey of HCPs. This has resulted in pharma companies being more relevant and providing more value in closing the care gap, the report says. The Accenture survey of 720 general practitioners, oncologists, cardiologists and immunologists globally found that this is in turn helping HCPs better serve patients.

Communication 128

Communication Pharmaceutical Companies Pharmaceutical Companies 128

Pharma Mirror

AUGUST 17, 2020

When you many patients think of a doctor’s office, hospital, or healthcare facility, they picture a stuffy, cold, and outdated facility that increases your anxiety. Offices with old decor prevent patients from visiting the doctor regularly and feeling relaxed. But what if there was a way to modernize the office affordably to make it more. The post 5 Ways That Digital Signage Improves a Doctor’s Office appeared first on Pharma Mirror Magazine.

Hospitals 98

Hospitals 98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

AUGUST 19, 2020

Following a pause because of coronavirus, the company has now kicked off the second part of a trial assessing a pressurised metered-dose inhaler formulation of ensifentrine

106

106

NY Times

AUGUST 17, 2020

The goal of the initiative is admirable: getting a coronavirus vaccine out to Americans and saving lives as soon as possible. It is not, however, without its problems.

Vaccines 100

Vaccines 100

Outsourcing Pharma

AUGUST 19, 2020

A leader from the clinical laboratory and diagnostic solution provider discusses how its research is fueled by partnerships and patient-centricity.

104

104

Pharma Times

AUGUST 19, 2020

AZ says approval would “simplify and improve treatment by enabling continuity of care while minimising the risk of exposure to infection in the healthcare setting”

99

99

NY Times

AUGUST 19, 2020

A ruined economy and a broken health care system have left President Nicolás Maduro unable to fight the pandemic as other world leaders have. Instead, he’s detained thousands to try to halt the spread.

93

93

pharmaphorum

AUGUST 17, 2020

Sanofi is to buy Principia Biopharma for up to $3.68 billion, adding a potential multiple sclerosis drug to its pipeline. The French pharma said it will pay $100 per share in cash for San Francisco-based Principia, which specialises in Bruton’s kinase (BTK) inhibitor drugs, after the deal was unanimously agreed by both boards of directors. Sanofi’s acquisition builds on a partnership to develop central nervous system drugs that began in late 2017.

Immunity 121

Immunity Immunization Diabetes 121

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Outsourcing Pharma

AUGUST 17, 2020

Researchers at Novateur Ventures have released a strategy that examines leukotrienes as the cause for hyperinflammatory response in severe cases.

105

105

Pharma Times

AUGUST 18, 2020

Enspryng is the first approved therapy for NMOSD designed to target and inhibit interleukin-6 receptor activity, using novel recycling antibody technology

106

106

NY Times

AUGUST 19, 2020

Una economía destruida y un sistema de salud colapsado han dejado al país sin capacidad para combatir la pandemia como lo han hecho otras naciones. En cambio, el gobierno ha desplegado sus fuerzas de seguridad para tratar de contener la propagación.

79

79

pharmaphorum

AUGUST 21, 2020

Pfizer and BioNTech have said their COVID-19 vaccine could be ready for regulators to review by October and approved by the end of the year after releasing more favourable data from an early-stage trial. There are no vaccines approved for COVID-19 and governments across the world are striking deals with various manufacturers to get early access once regulators give them the rubber stamp.

Vaccines 120

Vaccines 120

Outsourcing Pharma

AUGUST 18, 2020

The CDMO is expanding its small-molecule manufacturing capacity with a new 8,500-square-meter production facility at its Visakhapatnam, India site.

98

98

Pharma Times

AUGUST 18, 2020

High SABA inhaler use was associated with around twice the number of exacerbations, the SABINA study found

119

119

NY Times

AUGUST 20, 2020

In addition to concerns over mail-in voting, the cost-cutting at the Postal Service affects the millions of people who get their prescriptions by mail.

72

72

pharmaphorum

AUGUST 20, 2020

David Keene looks at the difficulties faced in treating mental health patients and how digital technologies are changing the game. In 1919 a young Dwight Eisenhower participated in a cross-country road trip to deliver tanks from Fort Meade in Maryland to San Francisco. Most of the roads on the journey were muddy, rut filled trails, and after 62 days at an average speed of 5 miles per hour, the convoy finally arrived.

Communication 120

Communication 120

Outsourcing Pharma

AUGUST 18, 2020

A leader from home-based clinical services firm Illingworth Research Group talks about the evolution of mobile nursing and how it can keep trials going.

93

93

Pharma Times

AUGUST 19, 2020

Plans have been announced to test 150,000 people per fortnight across the UK from October

128

128

NY Times

AUGUST 20, 2020

Researchers are testing an experimental drug to halt sudden outbreaks. The trial may bring a new type of treatment for the virus.

Nursing Homes 76

Nursing Homes 76

pharmaphorum

AUGUST 21, 2020

It’s mission accomplished for Novartis after the FDA approved ofatumumab for multiple sclerosis, completing a project where the former cancer drug has been repurposed. The FDA approved ofatumumab under the brand name Kesimpta for people living with relapsing forms of multiple sclerosis. Kesimpta will have a list price of around $83,000 a year, which the company argues will make it one of the lowest-cost branded options in a highly competitive market where drugs like Sanofi’s Aubagio and Roche’s

Hospitals 113

Hospitals 113

Outsourcing Pharma

AUGUST 20, 2020

A leader from the clinical research technology firm talks about the importance of a diverse patient population and ways to hit the target.

81

81

Pharma Times

AUGUST 20, 2020

The approval broadens the drug's label to include fifth treatment option in the relapsed/refractory multiple myeloma setting

Labelling 108

Labelling 108

Eye on FDA

AUGUST 18, 2020

Each year, midway through it all, I take a look back to see what FDA has been talking about and compare it to the year before to see how things may have changed. I’m a little late at getting to it this year due to all the COVID-19 distraction. But it is not likely to surprise anyone that the first half of 2020 has caused not only an increase in communication from FDA, but a focus as well.

Communication 61

Communication Documentation Labelling 61

pharmaphorum

AUGUST 16, 2020

Swittons , a P360 company, has announced a new line of Internet of Things (IoT) enabled smart devices built specifically for pharmaceutical labs. The fully customizable devices align with strategic Lab of the Future (LoTF) initiatives and help automate various laboratory workflows between people and existing digital lab equipment, systems and solutions.

111

111

Outsourcing Pharma

AUGUST 18, 2020

A leader from the clinical trial patient engagement specialist discusses how clinical trial teams can tackle tricky travel issues in the face of the pandemic.

72

72

Pharma Times

AUGUST 17, 2020

The move bolsters the French drug giant's core R&D areas of autoimmune and allergic diseases

107

107

Drug Patent Watch

AUGUST 19, 2020

When drug patents expire, billions of dollars in revenues can disappear overnight as competitors enter the market. Accordingly, many investors focus on drug patents when evaluating drug companies. But, there…. The post Investing in Drug Companies? Here are 6 Vital Non-Patent Factors to Consider appeared first on DrugPatentWatch - Make Better Decisions.

59

59

pharmaphorum

AUGUST 16, 2020

The European Commission has placed its first advance order for a coronavirus vaccine, snapping up 300 million doses of AstraZeneca’s ChAdOx1 candidate developed by the University of Oxford, with an option on another 100 million. ChAdOx1 – which is in large-scale phase 2/3 trials – was licensed by AZ in April and renamed AZD1222, and should be ready for first deliveries before the end of the year.

Vaccines 109

Vaccines Immunity Immunization 109

Outsourcing Pharma

AUGUST 19, 2020

An online patient community specializing in rare diseases has launched Xperiome, a knowledge platform aimed at speeding development of treatments.

72

72

Pharma Times

AUGUST 20, 2020

Findings also show increased trust in pharma and healthcare

129

129

Drug Patent Watch

AUGUST 19, 2020

This article was originally published by Mahendra Saini, Nikhita Parihar, Shankar Lal Soni, and Vandana Sharma in the Asian Journal of Pharmaceutical Research and Development. 2020; 8(4): 194-212 under an…. The post Drug Repurposing: An Overview appeared first on DrugPatentWatch - Make Better Decisions.

59

59

pharmaphorum

AUGUST 19, 2020

UK digital health company Sensyne Health has launched a new smartphone app to help people across the diabetes spectrum manage their condition. The app – called DBm-Health – can help users to monitor their blood glucose levels and send readings, notes and medication information to their healthcare practitioner to assess remotely. It is a follow-on to Sensyne ’s GDm-Health product, which is used for remote monitoring of diabetes during pregnancy and was recently made available for free to all NHS

Diabetes 104

Diabetes 104

Pharma Marketing Network

AUGUST 18, 2020

In the wake of the sales field disruption, DHC Group’s Mark Bard held a roundtable with several physician communication experts to discuss how marketers should move forward to insulate against channel dependence in the future. While the phrase “ Our expert panel focused on that reality and what the omnichannel of the future might look like.” is not new, the concept of building an HCP communication plan that isn’t significantly impacted by the loss of one channel or another is less developed.

Communication 59

Communication 59